Ifp Advisors, Inc Harmony Biosciences Holdings, Inc. Transaction History
Ifp Advisors, Inc
- $3.28 Billion
- Q2 2025
A detailed history of Ifp Advisors, Inc transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 6,686 shares of HRMY stock, worth $210,140. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,686
Previous 4,606
45.16%
Holding current value
$210,140
Previous $152,000
38.82%
% of portfolio
0.01%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding HRMY
# of Institutions
293Shares Held
46.1MCall Options Held
316KPut Options Held
69.9K-
Valor Management LLC Chicago, IL6.62MShares$208 Million88.32% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$183 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$160 Million0.0% of portfolio
-
State Street Corp Boston, MA1.63MShares$51.2 Million0.0% of portfolio
-
Lsv Asset Management Chicago, IL1.59MShares$50.1 Million0.1% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.86B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...